Six piperazine derivatives 6a-f containing 1,4-benzodioxan moiety have been synthesized and characterized by 1 H NMR, ESI-MS and elemental analysis. The structure of 6d was further confirmed by single crystal X-ray diffraction. All these novel compounds were screened for their in vivo anti-inflammatory activity employing classical para-xylene-induced mice ear-swelling model. The results revealed that most of the target compounds showed significant anti-inflammatory activities, especially compound 6a with ortho-substituted methoxy group on the phenylpiperazine ring exhibited the best activity among the designed compounds.
Introduction
Inflammation, a biological process response to harmful stimuli or infection, has threatened human health seriously. [1] [2] [3] Nonsteroidal anti-inflammatory drugs (NSAIDs) like diclofenac, indomethacin and naproxen are widely clinically used drugs for inflammatory disorders such as arthritis, peritendinitis and lupus erythematosus. [4] [5] [6] [7] However, long-term use of NSAIDs has been associated with adverse side effects, including gastrointestinal ulceration, and even fatal internal bleeding. 8 The stomach damage from NSAIDs is generally attributed to their acidic character as most of them are weak acids with pK a values ranging from 3 to 5. 8, 9 Therefore, synthetic approaches based on design of non-acidic anti-inflammatory lead compounds have gained great interest nowadays. 1, [10] [11] [12] [13] Piperazine group, as a known pharmacophore, is part of many important alkaline heterocyclic compounds displaying a broad range of biological activities, e.g. antibacterial, 14 anti-tumor, 15 antidiabetic, 16 and anti-psychiatry. 17 Continuous efforts have also been made to prepare anti-inflammatory therapeutic agents containing piperazine scaffold. Li et al. reported a series of chalcone derivatives containing aryl-piperazine or aryl-sulfonyl-piperazine fragment and found compound A (Figure 1 ) as a potential anti-inflammatory agent. 18 Silva et al. evaluated the anti-inflammatory effect of 4-[(1-phenyl-1H-pyrazol-4-yl) methyl]-1-piperazinecarboxylic acid ethyl ester (B, Figure  1 ) and the involvement of the serotonergic pathway. 3 Mao Figure  1 ), the in vitro anti-inflamatary activity evaluation indicated that theses compounds showed good inhibitory effect on the generation of inflammatory factor, NO. 19 A series of piperazine analogues bearing pyridine or thiophene moieties have been synthesized by Kumar et al. (D, Figure 1 ), they also showed favorable anti-inflammatory efficacy. 20 Beyond that, it was reported that 1,4-benzodioxan afforded a new skeleton possessing anti-inflammatory activity. 10, 21, 22 Potent anti-inflammatory activity of analogues containing 1,4-benzodioxan ring may be ascribed to the strong hydrogen-bonding interactions with amino acids in the active domain. 10 As mentioned above, it is a worthwhile goal to synthesize compounds containing piperazine and 1,4-benzodioxan rings utilizing molecular hybridization approach. The presence of the two bioactive skeltons in a single molecular frame may lead to potent derivatives possessing good anti-inflammatory activity. 10 With this in mind, we have synthesized six compounds (6a-f) possessing piperazine and 1,4-benzodioxan moieties (Scheme 1). Spectral analyses using ESI mass spectrometry and 1 H NMR spectroscopy have been applied in order to affirm the structure of the synthesized molecules. Furthermore, the synthesized molecules have been subjected to in vivo anti-inflammatory evaluation.
Experimental

1. Physical Measurements and Materials
Reagents and solvents used in this study were analytical grade and purchased commercially from Aladdin Industrial Corporation (China). 1 
General Procedure for the Synthesis of Target Compounds 6a-f
To a solution of a substitued phenylpiperazines (6.0 mmol) in CH 2 Cl 2 (30 mL) containing triethylamine (1 mL), chloroacetyl chloride (0.48 mL, 6.0 mmol) was added dropwise with stirring in ice water bath. Stirring was continued for 5 h and the reaction mixture was washed with 10% NaOH solution (2 × 5 mL). The organic layer was collected. After drying with anhydrous Na 2 SO 4 , the solvent was removed in vacuo to yield the intermediate 5a-f.
Oxadiazole derivative 4 (0.24 g, 1.0 mmol) and KOH (0.056 g, 1.0 mmol) dissolved in CH 3 OH (20 mL) was treated with chloro derivatives 5a-f (1.0 mmol). The mixture was stirred at room temperature about 4 h until the solid was precipitated. The solids 6a-f were filtered and purified by recrystallization from MeOH. (5-(2,3-Dihydrobenzo[b][1,4]dioxin-7-yl)-1,3,4-oxadiazol-2-ylthio)-1-(4-(3-chlorophenyl) (5-(2,3-Dihydrobenzo[b][1,4]dioxin-7-yl)-1,3,4-oxadiazol-2-ylthio)-1-(4-(4-chlorophenyl)piperazin-1-yl 
2-(5-(2,3-Dihydrobenzo
[b][1,4]dioxin-7-yl)-1,3,4-oxa- diazol-2-ylthio)-1-(4-(2-methoxyphenyl)piperazin-1- yl)ethanone (6a
2-(5-(2,3-Dihydrobenzo[b][1,4]dioxin-7-yl)-1,3,4-oxadiazol-2-ylthio)-1-(4-(3-methoxyphenyl)piperazin-1-yl)ethanone (6b
2-
3. Determination of Crystal Structure for 6d
Crystal diffraction data for compound 6d were collected on a Bruker SMART APEX CCD-based diffractometer (Mo Kα radiation, λ = 0.71073 Å) at 298 K. Multi-scan absorption corrections were applied by SADABS. 25 The structures were solved by the directed method followed by Fourier syntheses. Structure refinement was performed by full-matrix least-squares procedures using SHELXL-97 program package. 26 Non-hydrogen atoms were refined using anisotropic thermal parameters. Hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms. Details of crystallographic parameters, data collection, and refinements are summarized in Table 1 . Relevant bond distances and bond angles are given in Table 2 .
4. In vivo Anti-Inflammatory Activities in Ear Edema
The animal studies were conducted according to the guideline issued by the State Food and Drug Administration (SFDA) of China. All experimental protocols were approved by the Animal Ethics Committee of Pingdingshan University. All efforts were made to minimize animal suffering. The anti-inflammatory activity was evaluated using in vivo para-xylene-induced mice ear-swelling model on Kunming mice, 18 35-40 days old and weighing 18-22 g, supplied by Jinan Pengyue Experimental Animal Breeding Company. Kunming mice were divided into eight groups of eight each. Group I, the control, comprised of animals treated with vehicle (0.5% CMC, 10 mL/kg), and groups II-VIII were dosage groups. Group II was treated with standard reference drug diclofenac (20 mg/kg), groups III-VIII were treated with target compounds 6a-f (30 mg/kg), respectively. One hour later, ear swelling was induced by smearing 50 μL para-xylene to each side of the right ears, the left ear served as a control. After 1 hour, the mice were sacrificed, and both ears at the same position were removed using a 6 mm diameter punch. Swelling degree and swelling inhibition were calculated according to the following formula:
Swelling degree (mg) = weight of right ear (mg) -weight of left ear (mg) Swelling inhibition (%) = (average swelling degree of control group -average swelling degree of dosage group) / average swelling degree of control group × 100%
Results and Discussion
1. Chemistry of Compounds 6a-f
Appropriate 2-chloro-1-(4-phenylpiperazin-1-yl) ethanone derivatives 5 were reacted with 5-(2,3-dihydrobenzo[b] [1, 4] dioxin-7-yl)-1,3,4-oxadiazole-2-thiol 4 in CH 3 OH/KOH solution via nucleophilic substitution reaction to furnish the respective target compounds 6a-f (Scheme 1). The structures of 6a-f were established by elemental and 1 H NMR and electrospray ionization mass spectrometry. In the 1 H NMR spectra of 6a-e, the protons of the piperazin ring resonated as four triplets appearing at δ 3.07-3.88 ppm. The multiplet corresponding to four protons characteristic of the -OCH 2 CH 2 -group was observed at δ 4.29-4.35 ppm. The -SCH 2 -protons appeared as a sharp singlet around δ 4.39 ppm. The protons of the substituted phenyl ring resulted in the formation of the resonance signal at δ 6.94-7.54 ppm. The methoxy protons of 6a-c appeared as a singlet at 3.78-3.89 ppm. The positive ion electrospray mass spectra of these compounds showed full abundance of the parent peak which corresponds to [M+Na)] + or [2M+Na)] + . Table 2 . Selected bond distances (Å) and angles (°) for 6d. Yellow crystals of 6d suitable for X-ray structure analysis were obtained by slow evaporation of a mixture of dichloromethane and methanol. X-ray single-crystal diffraction reveals that compound 6d crystallizes in monoclinic P2 1 /c space group. As shown in Figure 2 , 6d has a nonplanar chair-like conformation, the dihedral angle between 2-chlorobenzene ring and piperazine ring being 49.710(78)°; meanwhile the dihedral angle between 2-chlorobenzene ring and oxadiazole ring is 75.512(86)°. The piperazine ring in 6d has a classical chair conformation.
2. Crystal Structure
C(1)-O(1) 1.439(3) C(1)-C(2) 1.477(4) C(2)-O(2) 1.431(3) C(6)-C(9) 1.453(3) C(9)-N(1) 1.280(3) C(9)-O(3) 1.364(3) N(1)-N(2) 1.417(3) C(10)-N(2) 1.286(3) C(10)-O(3) 1.353(3) C(10)-S(1) 1.734(3) C(11)-S(1) 1.805(3) C(12)-N(3) 1.348(3) O(1)-C(1)-C(2) 111.0(2) O(2)-C(2)-C(1) 110.6(2) C(3)-O(1)-C(1) 114.1(2) C(8)-O(2)-C(2) 113.0(2) N(1)-C(9)-C(6) 130.3(2) N(
In vivo Anti-Inflammatory Activities
The anti-inflammatory activities of the synthesized piperazine derivatives 6a-f were tested using in vivo para-xylene-induced mice ear-swelling model. All the target compounds were adminstered at a dose of 30 mg/kg and diclofenac (20 mg/kg) was used as the reference drugs. The results show that compounds 6a, 6c, 6d, and 6f exhibited significant anti-inflamatory activities (p < 0.01) ( Table 3) . In the present assay, compound 6a bearing methoxy substituent at the ortho position of the phenyl piperazine showed the most effective anti-inflamatory activity; it was 1.3 times more active than diclofenac (inhibition values 68.02 vs. 52.03%). Preliminary structure-activity relationship analysis revealed that: (i) the substituent at different positions led to different activity, and the potency order was ortho > para > meta; (ii) in view of the comparison of the structures of compounds 6a with 6d, 6b with 6e, and 6c with 6f, the in vivo anti-inflammatory activities were 6a > 6d, 6b > 6e, and 6c > 6f. These results indicate that substitution at phenyl-piperazine with electron-donating methoxy group shows advantage over electron-withdrawing chlorine group at the same position, thus improving compound's anti-inflammatory activity. Meanwhile compared with the chalcone derivatives containing aryl-piperazine reported earlier, most of the compounds in the present assay were found to display enhanced in vivo anti-inflammatory activity. 18 Table 3 . Anti-inflammatory activities of the synthesized compounds 6a-f.
Compound
Swelling degree (mg) Inhibition (%) 
Conclusions
To sum up, a series of six piperazine derivatives 6a-f containing 1,4-benzodioxan moiety were synthesized and screened primarily for in vivo anti-inflammatory activities potential in ear edema. The substituent at different positions led to different activity. Most of the synthetic compounds emerged as effective in vivo anti-inflammatory agents, demonstrating swelling inhibition even better than the reference control, diclofenac. Compound 6a containing methoxy substituent at the ortho position of the phenyl piperazine displayed the most potent anti-inflammatory activity among the synthesized compounds. Our findings might provide information on developing potentially new and safe anti-inflammatory agents.
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